2.25% 1.34

Royalty Pharma Plc (RPRX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Royalty Pharma Plc Azioni (RPRX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	6.91% 674.14	630.58	621.99	609.29	578.66
Research and Development	145.92% 97.85	39.79	-	-	-
Costs And Expenses	701.06% 541.02	67.54	233.61	182.13	368.87
Operating Income/Loss	76.36% 133.12	563.04	388.38	427.16	209.80
Nonoperating Income/Loss	45.52% -51.63	-94.78	-32.47	17.05	-119.16
Income/Loss From Equity Method Investments	81.26% 4.077	21.76	4.005	15.95	2.693
Income/Loss From Continuing Operations Before Tax	82.60% 81.49	468.26	355.91	444.21	90.64
Income Tax Expense/Benefit	-	-	-	-	-
Net Income/Loss	82.60% 81.49	468.26	355.91	444.21	90.64
Attributable To Noncontrolling Interest	63.36% 63.60	173.57	141.71	155.99	60.46
Basic Average Shares	1.89% 445.06	436.79	-0.48	431.89	423.51
Diluted Average Shares	0.01% 556.90	556.84	-2.299	559.61	562.30
Basic Earnings Per Share	94.03% 0.04	0.67	0.50	0.67	0.07
Diluted Earnings Per Share	94.03% 0.04	0.67	0.50	0.67	0.07
Common Stock Dividends	0.00% 0.235	0.235	0.22	0.22	0.22

ROIV

$33.53

1.50%

ALNY

$231.83

0.94%

INCY

$113.07

0.18%

GMAB

$37.00

2.17%

BNTX

$87.71

2.76%

INSM

$96.27

2.96%